# Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

> **NCT03214952** · — · COMPLETED · sponsor: **Takeda** · enrollment: 3183 (actual)

## Conditions studied

- Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis

## Interventions

- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT03214952
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 3183 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03214952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03214952, "Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03214952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*